Publication Year: 2018
-
Early Diagnosis of Pulmonary Nodules: The Potential Effect of Observed Lymph Nodes on Performance of a Proteomic Biomarker
-
Early Diagnosis of Pulmonary Nodules: Relative Contributions by Clinical Factors, Imaging, and Proteomics to a Clinical Biomarker
-
Pulmonary Nodule Biomarker PANOPTIC study results at 1-year supported by 2-year results
-
A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
-
Highly Multiplexed Diagnostic Test for the Detection of Extended EGFR del19 Variants in Patients with NSCLC
-
Erlotinib Plus Either Pazopanib or Placebo in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer: A Randomized, Placebo-Controlled Phase 2 Trial With Correlated Serum Proteomic Signatures
-
Precision Medicine: Estimated Clinical and Economic Outcomes of Using a Predictive and Prognostic Biomarker to Avoid Ineffective Therapies in Advanced Non-Small Cell Lung Cancer
-
Prognostic role of the VeriStrat test in first line patients with non-small cell lung cancer treated with platinum-based chemotherapy
-
The serum-based VeriStrat test is associated with proinflammatory reactants and clinical outcomes in non-small cell lung cancer patients
-
Performance verification of a plasma-based PD-L1 test that reliably measures mRNA expression from patients with NCSLC